Approval times for supplemental indications for recombinant proteins

This new study shows that, in the US, approval of supplemental indications for recombinant protein products takes an average of seven months longer than approval of the original indication.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bio/technology (New York, N.Y. 1983) N.Y. 1983), 1997-02, Vol.15 (2), p.130-134
Hauptverfasser: Gosse, ME, Nelson, T F
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This new study shows that, in the US, approval of supplemental indications for recombinant protein products takes an average of seven months longer than approval of the original indication.
ISSN:0733-222X